Substance
NAPROXEN
Global reference: every product and company linked to this substance.
- cas: 22204-53-1
- ncit: C680
- pubchem_cid: 156391
- rxnorm: 7258
- unii: 57Y76R9ATQ
EC-NAPROSYN · NAPROSYN · naproxen [INN] · NAPROXEN [JAN] · NAPROXEN [USAN] · Naproxen [WHO-DD] · NSC-750183 · NSC-757239 · PN400 COMPONENT NAPROXEN · RS-3540
Revenue by product (0)
No revenue reported for this substance in loaded filings.
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (5)
- NAPROXEN · PERRIGO COMPANY PLC ORDINARY SHARES
- NAPROXEN AND ESOMEPRAZOLE MAGNESIUM · DR. REDDY'S LABORATORIES LTD COMMON STOCK
- PREVACID NAPRAPAC 250 (COPACKAGED) · TAKEDA PHARMACEUTICAL COMPANY LIMITED AMERICAN DEPOSITARY SHARES (EACH REPRESENTING 1/2 OF A SHARE OF COMMON STOCK)
- PREVACID NAPRAPAC 375 (COPACKAGED) · TAKEDA PHARMACEUTICAL COMPANY LIMITED AMERICAN DEPOSITARY SHARES (EACH REPRESENTING 1/2 OF A SHARE OF COMMON STOCK)
- PREVACID NAPRAPAC 500 (COPACKAGED) · TAKEDA PHARMACEUTICAL COMPANY LIMITED AMERICAN DEPOSITARY SHARES (EACH REPRESENTING 1/2 OF A SHARE OF COMMON STOCK)
Companies holding this asset (6)
- AMNEAL PHARMACEUTICALS INC. CLASS A COMMON STOCK
- ASTRAZENECA PLC ORDINARY SHARES
- DR. REDDY'S LABORATORIES LTD COMMON STOCK
- PERRIGO COMPANY PLC ORDINARY SHARES
- TAKEDA PHARMACEUTICAL COMPANY LIMITED AMERICAN DEPOSITARY SHARES (EACH REPRESENTING 1/2 OF A SHARE OF COMMON STOCK)
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED AMERICAN DEPOSITARY SHARES